[3H]Rolipram binding and phosphodiesterase activity in neuroblastoma N18TG-2 and glioma C6Bu-1

This publication has 9 references indexed in Scilit:

• Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram
  Biochemical Journal, 1993
• Characterization of 3':5' cyclic nucleotide phosphodiesterase activities of mouse neuroblastoma N18TG2 cells
  FEBS Letters, 1993
• Sequential alterations of [3H]rolipram and [3H]cyclic adenosine monophosphate binding in the gerbil brain following transient cerebral ischemia
  Brain Research, 1993
• Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes
  Trends in Pharmacological Sciences, 1991
• Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors
  Trends in Pharmacological Sciences, 1990
• Rolipram in Major Depressive Disorder: Results of a Double-Blind Comparative Study with Imipramine
  Pharmacopsychiatry, 1989
• Stereospecific binding of the antidepressant rolipram to brain protein structures
  European Journal of Pharmacology, 1986
• Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors
  Neuropharmacology, 1983
• DIFFERENTIATION OF NEUROBLASTOMA CELLS IN CULTURE
  Biological Reviews, 1975